Literature DB >> 9223329

Thymineless death in colon carcinoma cells is mediated via fas signaling.

J A Houghton1, F G Harwood, D M Tillman.   

Abstract

Fas is expressed constitutively in colonic epithelial cells and is also expressed in colon carcinomas and in cultured colon carcinoma cell lines. However, the potential role of Fas signaling in mediating apoptosis in cells of this type remains unknown. We have developed human colon carcinoma cell models deficient in thymidylate synthase that demonstrate acute (TS- cells) or delayed (Thy4 cells) apoptosis following DNA damage induced by thymineless stress. Complete protection of cells from acute apoptosis and prolongation of delayed apoptosis was obtained following exposure to the NOK-1 monoclonal antibody (inhibitory to Fas signaling) during the period of dThd deprivation. These results suggested that apoptosis induced by thymineless stress was regulated by autocrine signaling via Fas-FasL interactions. Fas expression was high in both TS- and Thy4 cells. However, FasL, undetectable in synchronous cultures, was up-regulated in TS- cells at 48 hr, when cells were undergoing acute apoptosis, and in Thy4 cells at 96 hr, correlating with the delayed onset of thymineless death. FasL expression also correlated with acute apoptosis induced in parental GC3/cl cells, commencing at 48 hr, following thymidylate synthase inhibition by 5-fluorouracil/leucovorin exposure. Fas-mediated apoptosis induced by the cytotoxic anti-Fas monoclonal antibody CH-11 was inhibited following adenoviral delivery of a Bcl-2 cDNA, and Bcl-2 also protected cells from acute apoptosis induced by dThd deprivation. Taken together, these data demonstrate a functional Fas system in these cultured colon carcinoma cell models, and they demonstrate that Fas-FasL interactions can link DNA damage induced by thymineless stress to the apoptotic machinery of colon carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223329      PMCID: PMC21571          DOI: 10.1073/pnas.94.15.8144

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Differential expression of APO-1 on human thymocytes: implications for negative selection?

Authors:  K M Debatin; D Süss; P H Krammer
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

Review 2.  Development of the T cell receptor repertoire in lpr mice.

Authors:  S J Rozzo; R A Eisenberg; P L Cohen; B L Kotzin
Journal:  Semin Immunol       Date:  1994-02       Impact factor: 11.130

Review 3.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

5.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.

Authors:  N Itoh; S Nagata
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.

Authors:  J A Houghton; C L Morton; D A Adkins; A Rahman
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

7.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

8.  Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.

Authors:  J A Houghton; D M Tillman; F G Harwood
Journal:  Clin Cancer Res       Date:  1995-07       Impact factor: 12.531

9.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.

Authors:  M Seto; U Jaeger; R D Hockett; W Graninger; S Bennett; P Goldman; S J Korsmeyer
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  32 in total

Review 1.  The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.

Authors:  William H Gmeiner; Waldemar Debinski; Carol Milligan; David Caudell; Timothy S Pardee
Journal:  Future Oncol       Date:  2016-06-09       Impact factor: 3.404

2.  Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.

Authors:  Liang Zong; Ping Chen; Da-Xin Wang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  The antioxidant n-acetylcysteine increases 5-fluorouracil activity against colorectal cancer xenografts in nude mice.

Authors:  S P Bach; S E Williamson; E Marshman; S Kumar; S T O'Dwyer; C S Potten; A J Watson
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

4.  Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.

Authors:  Tanvi S Jani; Jennifer DeVecchio; Tapati Mazumdar; Akwasi Agyeman; Janet A Houghton
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

5.  Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.

Authors:  I Meinhold-Heerlein; F Stenner-Liewen; H Liewen; S Kitada; M Krajewska; S Krajewski; J M Zapata; A Monks; D A Scudiero; T Bauknecht; J C Reed
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

6.  In vitro apoptotic effect on human lymphatic filarial parasite by piperidine derivatives and thymidine reversal study.

Authors:  Priyanka S Bhoj; Sahitya Rao; Sandeep P Bahekar; Nikita R Agrawal; Namdev S Togre; Richa Sharma; Kalyan Goswami; Hemant S Chandak; Mandakini B Patil
Journal:  Parasitol Res       Date:  2019-12-05       Impact factor: 2.289

7.  Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro.

Authors:  Raffaella Mele; Maria Angeles Gomez Morales; Fabio Tosini; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.

Authors:  Yong Huang; Haijun Yu; Han Lei; Conghua Xie; Yahua Zhong
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

9.  DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.

Authors:  Mianen Sun; Tong Zhou; Eric Jonasch; Richard S Jope
Journal:  Biochim Biophys Acta       Date:  2013-03-05

10.  Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines.

Authors:  Ivana Grivicich; Andréa Regner; Caroline Zanoni; Larissa Procópio Correa; Geraldo Pereira Jotz; João Antônio Pêgas Henriques; Gilberto Schwartsmann; Adriana Brondani da Rocha
Journal:  Int J Colorectal Dis       Date:  2007-03-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.